Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer Disease.
Journal: Neurology
Published: November 04, 2024
Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.
Journal: Journal of Alzheimer's disease : JAD
Published: July 12, 2024
Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy.
Journal: The Journal of experimental medicine
Published: November 01, 2023
Regulation of astrocyte lipid metabolism and ApoE secretionby the microglial oxysterol, 25-hydroxycholesterol.
Journal: Journal of lipid research
Published: May 03, 2022
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.
Journal: Brain : a journal of neurology
Published: January 25, 2022
Cognitively normal APOE ε4 carriers have specific elevation of CSF SNAP-25.
Journal: Neurobiology of aging
Published: December 26, 2020
Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia.
Journal: NeuroImage. Clinical
Published: December 12, 2019
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.
Journal: Cell
Published: August 05, 2019
Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model.
Journal: The Journal of experimental medicine
Published: June 02, 2019
Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5'-untranslated region: Implications in Alzheimer's disease.
Journal: Molecular psychiatry
Published: May 18, 2018
Last Updated: 09/26/2026